In VivoNeurodegenerative disorders affect over 50 million people globally, with prevalence rising due to increased life expectancy. These conditions lead to progressive cognitive and motor decline, often res
ScripEven with less venture capital raised during the first quarter of 2022 than in Q1 of 2021, VC financing has become the most common type of financing for biopharmaceutical firms raising cash in 2022, a